Published in Clin Rheumatol on August 19, 2012
Clinical Assessment and Management of Spondyloarthritides in the Middle East: A Multinational Investigation. Int J Rheumatol (2015) 0.78
Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab. BMC Musculoskelet Disord (2015) 0.77
Evaluation of multiple referral strategies for axial spondyloarthritis in the SPondyloArthritis Caught Early (SPACE) cohort. RMD Open (2017) 0.75
Assessment of clinical efficacy and safety in a randomized double-blind study of etanercept and sulfasalazine in patients with ankylosing spondylitis from Eastern/Central Europe, Latin America, and Asia. Rheumatol Int (2016) 0.75
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum (1984) 20.51
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol (1994) 11.17
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis (2009) 8.37
Ankylosing spondylitis. Lancet (2007) 6.58
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis (2009) 4.37
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum (2005) 3.31
Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int (2002) 2.95
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect. Ann Rheum Dis (1997) 2.33
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis (2005) 2.21
Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum (1995) 2.16
Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum (2006) 1.99
Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum (2009) 1.98
Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol (1988) 1.96
No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial. Ann Rheum Dis (2006) 1.94
Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. Ann Rheum Dis (2006) 1.86
Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum (2009) 1.76
Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol (2006) 1.57
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial. Ann Rheum Dis (2008) 1.49
The spondyloarthropathies in Zimbabwe: a clinical and immunogenetic profile. J Rheumatol (1990) 1.49
Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care. Ann Rheum Dis (2004) 1.49
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks. Ann Rheum Dis (2005) 1.35
Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period. Arthritis Rheum (2008) 1.27
Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol (1998) 1.20
First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Rheumatology (Oxford) (2012) 1.19
Six months open label trial of leflunomide in active ankylosing spondylitis. Ann Rheum Dis (2005) 1.14
The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress. Ann Rheum Dis (2011) 1.07
Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol (2000) 1.07
Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis. Clin Rheumatol (2010) 0.97
Ankylosing spondylitis in sub-Saharan Africa. Postgrad Med J (2009) 0.92
Ankylosing spondylitis in African Blacks. Arthritis Rheum (1980) 0.91
The demographic and clinical spectrum of Arab versus Asian patients with ankylosing spondylitis in the UAE. Rheumatol Int (1998) 0.88
Two distinct patterns of ankylosing spondylitis in Moroccan patients. Rheumatol Int (2009) 0.87
Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol (2007) 0.86
The challenge of early diagnosis in ankylosing spondylitis. J Rheumatol (2007) 0.85
Interferon-γ release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders. Curr Opin Rheumatol (2011) 0.85
Ankylosing spondylitis and its association with the histocompatibility antigen HL-A B27: an epidemiological and clinical study. Rheumatol Rehabil (1978) 0.85
Profile of ankylosing spondylitis in Saudi Arabia. Clin Rheumatol (1996) 0.84
The HLA-B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus-infected patients with slow progression to acquired immunodeficiency syndrome. Arthritis Rheum (2005) 0.80
Spondyloarthropathies in patients attending the rheumatology unit of Lomé Hospital. J Rheumatol (1993) 0.80
Ankylosing spondylitis in rheumatology patients in Ouagadougou (Burkina Faso). Clin Rheumatol (2009) 0.80
Predicting outcome in ankylosing spondylitis. Rheumatology (Oxford) (2008) 0.79
Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint Bone Spine (2007) 0.79
Predictive factors of severity of spondyloarthropathy in North Africa. Br J Rheumatol (1995) 0.77
Validation of the Tunisian versions of Bath Ankylosing Spondylitis Functional Index (BASFI) and Disease Activity Index (BASDAI). Tunis Med (2009) 0.75
Ankylosing spondylitis and reactive arthritis in the developing world. Best Pract Res Clin Rheumatol (2008) 0.75
Can Islamic prayers benefit spondyloarthritides? Case report of a patient with ankylosing spondylitis and increased spinal mobility after an intensive regimen of Islamic prayer. Rheumatol Int (2008) 0.75
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis (2010) 2.71
Identifying neuropathic pain among patients with chronic low-back pain: use of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale. Reg Anesth Pain Med (2005) 1.92
Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution? Clin Rheumatol (2012) 1.55
Tropical rheumatology--a global issue. Rheumatology (Oxford) (2009) 1.41
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Ann Rheum Dis (2011) 1.38
Rheumatoid arthritis in the developing world. Best Pract Res Clin Rheumatol (2003) 1.13
The clinical utility of accelerometry in patients with rheumatoid arthritis. Rheumatology (Oxford) (2013) 0.98
Social aspects of living with rheumatoid arthritis: a qualitative descriptive study in Soweto, South Africa - a low resource context. Health Qual Life Outcomes (2008) 0.98
Ehlers-Danlos syndrome type IV in a young man. J Rheumatol (2006) 0.98
Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study. Pediatr Rheumatol Online J (2014) 0.97
Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol (2006) 0.95
Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis. Mediators Inflamm (2013) 0.89
Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis. Mediators Inflamm (2011) 0.86
Genetic diversity in black South Africans from Soweto. BMC Genomics (2013) 0.86
HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis patients. Arthritis Res Ther (2011) 0.85
Purulent pericarditis due to co-infection with Streptococcus pneumoniae and Mycobacterium tuberculosis in a patient with features of advanced HIV infection. BMC Infect Dis (2007) 0.83
Invasive pneumococcal infection presenting as septic arthritis and Austrian-like syndrome involving the tricuspid valve in a patient with underlying HIV infection. Joint Bone Spine (2005) 0.83
Differential gene expression of MMP-1, TIMP-1 and HGF in clinically involved and uninvolved skin in South Africans with SSc. Rheumatology (Oxford) (2012) 0.82
Interleukin-1 receptor antagonist gene polymorphisms are associated with disease severity in Black South Africans with rheumatoid arthritis. Joint Bone Spine (2008) 0.81
Safety of tumor necrosis factor inhibitors use for rheumatoid arthritis and ankylosing spondylitis in Africa, the Middle East, and Asia: focus on severe infections and tuberculosis. Clin Rheumatol (2012) 0.81
The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis. Clin Rheumatol (2010) 0.80
Changes in physical activity measured by accelerometry following initiation of DMARD therapy in rheumatoid arthritis. Rheumatology (Oxford) (2014) 0.79
The practical value of biologics registries in Africa and Middle East: challenges and opportunities. Clin Rheumatol (2012) 0.79
The scourge of HIV infection in sub-Saharan Africa -- a rheumatological perspective. J Rheumatol (2011) 0.78
A three month controlled intervention of intermittent whole body vibration designed to improve functional ability and attenuate bone loss in patients with rheumatoid arthritis. BMC Musculoskelet Disord (2014) 0.77
Two mutations in the MTHFR gene associated with mild hyperhomocysteinaemia. S Afr Med J (2003) 0.77
The PTPN22 R620W polymorphism is not associated with systemic rheumatic diseases in South Africans. Rheumatology (Oxford) (2009) 0.76
Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward. Rheumatol Int (2011) 0.76
Auto-antibody testing in obstetric patients. S Afr Med J (2004) 0.75
Lack of association of eNOS(G894T) and p22phox NADPH oxidase submit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients. Clin Chim Acta (2005) 0.75
Autoimmune disease genetics. Clin Dev Immunol (2012) 0.75
Antiphospholipid antibodies in black south africans with hiv and acute coronary syndromes: prevalence and clinical correlates. BMC Res Notes (2011) 0.75
Relationship of Visceral Fat and Adipokines with Cardiometabolic Diseases in Psoriasis. Acta Derm Venereol (2019) 0.75
Rheumatoid arthritis in the developing world: stepping up to the challenge. Clin Rheumatol (2014) 0.75